Boston Scientific is in the news again, this time announcing FDA approval of two spinal cord stimulation (SCS) leads for use with its Precision Plus System. The Precision Plus, used in the management of chronic intractable pain, provides spinal cord stimulation from an implantable pulse generator via flexible leads. The Linear 3-4 and Linear 3-6 Percutaneous Leads recently approved allow wider contact spacing, expanding the range currently available and giving physicians greater flexibility in lead configuration.
Boston Scientific touts its product’s remote control and automatic impedance adjustment, taking into account the body’s gradual encapsulation of the device leads to deliver a steady amount of current.
Press release: Boston Scientific Announces FDA Approval of New Leads for the Precision Plus™ Spinal Cord Stimulator System
Boston Scientific Announces FDA Approval of Two Precision Plus SCS Leads
August 2nd, 2010 
Aaron Rulseh Anesthesiology